Artículos del centro: Sarum Road Hospital - part of Circle Health Group Más de 6749 artículos avalados por los mejores especialistas médicos

A microscopic view of a metastatic cancerous cell.
Dr Sathish Harinarayanan

Por Dr Sathish Harinarayanan
24.04.24
Oncología Radioterápica

MRL-SABR for oligometastatic disease

MRL-SABR (magnetic resonance linac combined with stereotactic ablative radiotherapy) represents a paradigm shift in the management of oligometastatic disease, offering a targeted and minimally invasive treatment option with the potential for improved outcomes. Here, Dr Sathish Harinarayanan, renowned consultant clinical oncologist, provides an expert insight into the intricacies of MRL-SABR.

perineal trauma, childbirth, pregnancy, birth plan, caesarean section, vaginal delivery
Ms Sameena Muzaffar

Por Ms Sameena Muzaffar
02.11.23
Ginecología y Obstetricia

Perineal trauma and childbirth: Expert insight on treatment

Ms Sameena Muzaffar, a respected obstetrician and gynaecologist, provides insights on the short and long-term impacts of perineal trauma from childbirth in this informative article. Covering management and treatment of this injury, the leading specialist addresses common queries and offers expert advice for women with perineal trauma.

knee arthroscopy, knee pain, minimally invasive surgery, cartilage repair, ligament reconstruction
Mr Christopher Arthur Bailey

Por Mr Christopher Arthur Bailey
26.09.23
Traumatología

Knee arthroscopy: Your questions answered by an expert

We invited esteemed consultant orthopaedic surgeon Mr Christopher Bailey to share his wealth of expertise on knee arthroscopy. From the associated risks and benefits, to how the minimally invasive procedure differs from traditional open surgery, Mr Bailey provides key information and guidance patients preparing for knee arthroscopy in this informative article.

Mr Werner Struss

Por Mr Werner Struss
28.03.23
Urología

Prostate cancer screening and diagnosis

The European Urology Association recommends that men should initiate early detection for prostate cancer screenings, at an individual level, beginning from the age of 50 if they do not have a family history of prostate cancer or who are not of African descent. On the other hand, men who do have a family history of prostate cancer or who are of African descent should begin prostate cancer screening from the age of 45 years. Men who carry BRCA2 mutations should start their screening at 40 years of age. Individuals, both male and female, with these mutations are more prone to suffer from early onset of breast, ovarian or prostate cancer in these male and female individuals).

Mostrando resultados 10 de 24

Artículos médicos más leídos

Artículos médicos destacados

Búsquedas rápidas

Este sitio web utiliza Cookies propias y de terceros para recopilar información con la finalidad de mejorar nuestros servicios, para mostrarle publicidad relacionada con sus preferencias, así como analizar sus hábitos de navegación. El usuario tiene la posibilidad de configurar sus preferencias AQUI.
Rechazar
Solo esenciales
Aceptar todo
Configuración personalizada | Política de Cookies | Política de privacidad